Manchester Capital Management LLC purchased a new position in shares of Genpact Limited (NYSE:G – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 882 shares of the business services provider’s stock, valued at approximately $38,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. SRH Advisors LLC acquired a new stake in shares of Genpact during the 4th quarter worth approximately $26,000. UMB Bank n.a. increased its holdings in Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after purchasing an additional 433 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in Genpact by 74.6% in the 3rd quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock valued at $103,000 after purchasing an additional 1,121 shares during the last quarter. Versant Capital Management Inc increased its holdings in Genpact by 17.0% in the 4th quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock valued at $136,000 after purchasing an additional 461 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its holdings in Genpact by 22.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider’s stock valued at $145,000 after purchasing an additional 619 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Genpact Price Performance
Genpact stock opened at $55.06 on Friday. The stock has a market cap of $9.71 billion, a P/E ratio of 19.39, a price-to-earnings-growth ratio of 1.63 and a beta of 1.20. The company has a fifty day simple moving average of $46.03 and a 200-day simple moving average of $42.08. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.
Genpact Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be given a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, March 11th. This is a boost from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.24%. Genpact’s payout ratio is 21.48%.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on G shares. Robert W. Baird lifted their target price on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a report on Friday, November 8th. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $45.00 to $60.00 in a report on Friday, February 7th. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and raised their price target for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Needham & Company LLC raised their price target on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, Genpact presently has an average rating of “Hold” and an average target price of $48.44.
View Our Latest Stock Report on G
Insider Activity at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of the business’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at $11,926,218.40. The trade was a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 35,058 shares of company stock valued at $1,558,675 over the last ninety days. Insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Market Cap Calculator: How to Calculate Market Cap
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- How to Most Effectively Use the MarketBeat Earnings Screener
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.